Fuda Cancer Hospital
Cervical cancer treatment cost in China typically ranges from Price on request to Price on request for systemic therapies, while surgical interventions like a hysterectomy run from $11,500 to $22,500. Total expenses depend on the clinical stage, facility accreditation, and the use of advanced technologies. Patients often save approximately 40-70% compared to US healthcare prices. Top medical hubs include Beijing and Guangzhou.
Typical Cervical Cancer Treatment Costs in China
Bookimed Expert Insight: Advanced stage patients find the best value at specialized oncology centers in Guangzhou. Fuda Cancer Hospital is the first JCI-accredited facility in China. They specialize in late-stage cases using unique technologies like NanoKnife and cryosurgery. Clinical leaders like Professor Liu Shi Xin offer expert radiation oncology protocols. This expertise is vital for patients requiring complex, multidisciplinary care plans.
| China | Turkey | Austria | |
| Сervix Conization | from $1,850 | from $1,200 | from $2,800 |
| Uterine Trachelectomy | from $9,800 | from $5,500 | from $14,500 |
| Trachelectomy (cervicectomy) | from $14,200 | from $2,500 | from $15,000 |
| Tomotherapy | from $17,500 | from $8,440 | from $30,000 |
| The Wertheim-Meigs operation | from $17,500 | from $36,486 | from $22,000 |
Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.
Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.
Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.
Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.
He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.
Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.
He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).
Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).
He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.
Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.
Written by Veronika Kazina
Invasive cervical cancer treatment in China uses a multimodal approach combining surgery, radiation, and chemotherapy. Early-stage patients often undergo radical hysterectomy or fertility-preserving trachelectomy. Locally advanced cases typically receive concurrent chemoradiotherapy. Specialized oncology centers also integrate traditional medicine and minimally invasive technologies like Cryosurgery and NanoKnife.
Bookimed Expert Insight: Chinese oncology centers often favor minimally invasive local destruction over systemic chemotherapy for advanced stages. For example, Fuda Cancer Hospital provides over 10 types of local therapies. This allows doctors to treat 30,000+ patients from 100 countries. Some CyberKnife packages in Guangzhou may cost around $7,750. These packages often include consultations, medications, and clinic transfers as standard.
Patient Consensus: Patients note that top-tier hospitals deliver care matching global standards, particularly for advanced radiation techniques like high-dose brachytherapy. Many emphasize the importance of budgeting for traditional medicine add-ons used to support immunity during recovery.
China offers advanced non-invasive therapies for cervical cancer including High-Intensity Focused Ultrasound (HIFU) and APL-1702 photodynamic therapy. Specialized centers like Fuda Cancer Hospital utilize NanoKnife and cryosurgery for late-stage cases. These technologies target tumors while preserving the structural integrity of the cervix.
Bookimed Expert Insight: Patients seeking non-invasive options should note that Guangzhou is a primary hub for specialized oncology. Fuda Cancer Hospital has treated over 30,000 international patients with minimally invasive methods. Facilities here often combine traditional treatments with unique technologies like vascular interventional therapy for stage 3 or 4 cases. Choosing a JCI-accredited clinic in this region ensures adherence to international safety standards while accessing local innovations.
Patient Consensus: Patients note it is important to confirm if specific technologies like CyberKnife M6 are included in fixed-price packages. Many choose Chinese centers specifically to avoid invasive surgery and preserve their ability to have children.
China hosts specialized JCI-accredited facilities prioritizing international patients for cervical cancer care. Leading centers like Fuda Cancer Hospital utilize minimally invasive technologies. Chinese oncology groups also offer advanced stereotactic radiosurgery for cervical tumors. These institutions manage cases from over 100 countries including complex stages.
Bookimed Expert Insight: While major public academic centers lead in research, private JCI-accredited hospitals offer better logistical value. For instance, packages at Jinshazhou Hospital for CyberKnife M6 radiosurgery cost around $7,700 and include transfers. These private facilities often bundle medical services with medications and consultations, which simplifies care compared to navigating public wards.
Patient Consensus: Patients note that hiring a bilingual medical concierge is essential for navigating public hospitals. Many prefer international wings for better language support and clearer communication during chemotherapy.
Traditional Chinese Medicine (TCM) integrates with cervical cancer treatment as an adjuvant therapy to reduce side effects and boost immunity. Chinese oncology centers combine herbal formulas, acupuncture, and dietary therapy with surgery or radiation. This integrative approach aims to improve overall survival and patient quality of life.
Bookimed Expert Insight: Leading Chinese centers like Jinshazhou Hospital of Guangzhou University of Chinese Medicine directly incorporate TCM specialists into oncology teams. While many clinics offer separate services, top-tier facilities manage CyberKnife or radiotherapy packages alongside intensive TCM protocols. This ensures herbal prescriptions are synchronized with high-precision treatments for better patient tolerance.
Patient Consensus: Patients note that receiving TCM directly from hospital oncology teams is more effective than seeing solo practitioners. Many describe acupuncture as a game-changer for easing post-radiation pain and persistent treatment fatigue.
China is a safe destination for cervical cancer treatment when patients select Joint Commission International accredited facilities in major cities. Top-tier hospitals utilize advanced technology like the CyberKnife M6 and DaVinci robot. These centers follow strict safety protocols under National Health Commission oversight.
Bookimed Expert Insight: While many countries focus on traditional chemotherapy, Chinese oncology centers like Fuda Cancer Hospital specialize in over 10 types of minimally invasive therapies. These include cryosurgery and NanoKnife. This approach is highly effective for late-stage patients who cannot endure the physical strain of standard systemic treatments.
Patient Consensus: Patients note that navigating care requires strong local support due to language barriers and different hospital systems. Many stress the importance of securing a reliable translator or choosing a center with a dedicated international department to avoid communication errors.